Alprostadil side effects vary significantly depending on the method of administration and the condition being treated. For men using intracavernosal injections or urethral suppositories for erectile dysfunction, common side effects include penile pain, minor bleeding, and prolonged erections. In neonatal care, where it is used to maintain heart function, side effects are more systemic, including apnea, fever, and low blood pressure.
Alprostadil is a synthetic version of prostaglandin E1 (PGE1), a naturally occurring compound in the body that promotes vasodilation (the widening of blood vessels) and inhibits platelet aggregation. Because it acts directly on smooth muscle tissue, its effects are potent and immediate. However, this direct action also leads to a specific profile of adverse reactions that patients and caregivers must monitor closely in 2026.
Clinical Applications and Mechanism of Action
To understand why alprostadil causes specific side effects, one must first understand its physiological role. Alprostadil works by increasing the levels of cyclic adenosine monophosphate (cAMP) within smooth muscle cells. This biochemical shift leads to the relaxation of the trabecular smooth muscle and the dilation of cavernosal arteries. In the context of erectile dysfunction (ED), this allows blood to flow into the penis and remain trapped, creating an erection.
In pediatric cardiology, alprostadil (often branded as Prostin VR Pediatric) is used to maintain the patency of the ductus arteriosus in neonates with congenital heart defects. By preventing this duct from closing, the medication ensures that oxygenated blood can continue to circulate until surgical intervention is possible.
Because the drug is rapidly metabolized—often within a single pass through the lungs—its side effects are frequently localized to the site of administration in adults, whereas in infants receiving systemic infusions, the effects are widespread.
Side Effects of Intracavernosal Injections (Caverject, Edex)
Intracavernosal injection (ICI) involves injecting alprostadil directly into the side of the penis. This method is highly effective but carries the highest risk of localized tissue reactions.
Penile Pain and Discomfort
The most frequently reported side effect of alprostadil injections is penile pain. Clinical data suggests that roughly 30% to 40% of users experience some level of discomfort. This is often described as a dull ache or a "burning" sensation that occurs during the erection. The pain is believed to be caused by the prostaglandin's effect on sensory nerve endings. If the pain is severe enough to interfere with sexual activity, a dose adjustment or a change in the concentration of the diluent may be necessary.
Hematoma and Ecchymosis
Because the procedure involves a needle, minor bleeding and bruising (ecchymosis) at the injection site are common. In some cases, a small lump of clotted blood (hematoma) may form. This risk is higher in patients taking anticoagulants like warfarin or aspirin. Proper injection technique—applying firm pressure to the injection site for at least five minutes—is the primary method for reducing this risk.
Penile Fibrosis and Curvature
With long-term use, some patients develop penile fibrosis, which involves the formation of inelastic scar tissue within the tunica albuginea. This can lead to nodules, plaques, or a permanent curvature of the penis (similar to Peyronie’s disease). If fibrosis is detected, healthcare providers usually recommend pausing alprostadil therapy to prevent permanent deformity.
Side Effects of Intraurethral Suppositories (MUSE)
The Medicated Urethral System for Erection (MUSE) utilizes a small pellet inserted into the urethra. While it avoids the use of needles, it introduces a different set of side effects.
Urethral Burning and Aching
A significant portion of users (approximately 30%) report a burning sensation in the urethra. This is typically due to the local irritation of the mucosal lining. Urinating before insertion can help lubricate the area, but the sensation may persist until the medication is fully absorbed.
Minor Urethral Bleeding
Small abrasions during the insertion process can lead to "spotting" or minor urethral bleeding. This is generally self-limiting but can be distressing for the patient. Using a water-soluble lubricant or ensuring the applicator is properly aligned can minimize trauma.
Vaginal Irritation in Partners
Because the medication is placed in the urethra, a small amount of alprostadil can be transferred to the female partner during intercourse. This can cause vaginal burning or itching. In 2026, clinical guidelines recommend the use of a condom, especially if the partner is pregnant, as prostaglandins can theoretically induce uterine contractions.
Systemic Side Effects in Neonatal Care
When administered to newborns, alprostadil is given via continuous intravenous or intra-arterial infusion. The side effect profile in this population is critical and requires constant monitoring in a neonatal intensive care unit (NICU).
- Apnea: This is the most serious common side effect in infants, occurring in approximately 10% to 12% of cases. It is most prevalent in neonates weighing less than 2 kg at birth and usually appears within the first hour of infusion. Facilities must be prepared for immediate intubation and mechanical ventilation.
- Fever and Flushing: PGE1 is a known pyrogen. Many infants will develop a fever or significant skin flushing during the infusion. This is usually managed by adjusting the dose rather than discontinuing the life-saving medication.
- Bradycardia and Hypotension: Alprostadil's vasodilatory effects can lead to a drop in blood pressure and a slowed heart rate. Close hemodynamic monitoring is essential to balance the patency of the ductus arteriosus with cardiovascular stability.
- Cortical Proliferation: In infants requiring long-term infusion (weeks or months), alprostadil can cause the overgrowth of long bones (cortical proliferation). This is typically reversible once the medication is stopped following surgery.
Comparison of Side Effects by Formulation
The following table compares the prevalence and types of side effects across the three primary delivery methods for alprostadil.
| Side Effect Type | Intracavernosal (Injection) | Intraurethral (MUSE) | Neonatal IV Infusion |
|---|---|---|---|
| Local Pain | High (37%) | Moderate (20-30%) | Low (Injection site only) |
| Priapism Risk | Moderate (1-4%) | Low (<1%) | N/A |
| Fibrosis/Scarring | Possible with long-term use | Rare | N/A |
| Apnea | N/A | N/A | High (10-12%) |
| Hypotension | Rare/Systemic absorption | Rare | Common |
| Bleeding | Injection site bruising | Urethral spotting | N/A |
Serious Complications: Priapism and Cardiovascular Risks
While most side effects are localized or manageable, two conditions require urgent medical intervention.
Priapism (Prolonged Erection)
Priapism is defined as an erection lasting longer than four hours. This is a medical emergency. If blood remains trapped in the corpora cavernosa for too long, oxygen is depleted, leading to tissue hypoxia and eventual necrosis (tissue death). This can result in permanent erectile dysfunction.
Treatment for alprostadil-induced priapism usually involves the aspiration of blood from the penis and the injection of a sympathomimetic amine, such as phenylephrine, to constrict the blood vessels and allow drainage. Patients are strictly advised to seek emergency care if an erection persists beyond the four-hour mark.
Cardiovascular Events
In adult men, particularly those with pre-existing heart disease, the physical exertion of sexual activity combined with the potential systemic absorption of alprostadil can lead to dizziness, syncope (fainting), or even myocardial infarction. While alprostadil itself does not usually cause these events directly when used locally, the "first-dose" phenomenon involves a potential drop in blood pressure that should be monitored in a clinical setting during the initial titration.
Contraindications and Risk Factors
Not every patient is a candidate for alprostadil. Certain underlying conditions significantly increase the risk of severe side effects.
- Sickle Cell Anemia and Leukemia: Patients with conditions that predispose them to priapism should avoid alprostadil. Sickle cell trait or disease can cause red blood cells to "clump," making the resolution of an erection much more difficult.
- Anatomical Deformities: Men with Peyronie’s disease or significant penile curvature are at higher risk for worsened fibrosis and should use the drug with extreme caution.
- Penile Implants: Alprostadil is generally not used in men with functional penile implants, as the risk of infection or mechanical damage to the implant is high.
- Hypersensitivity: A known allergy to alprostadil or any components of the formulation (such as the alpha-cyclodextrin in certain brands) is a strict contraindication.
Drug Interactions
Alprostadil can interact with other medications, potentially exacerbating side effects:
- Antihypertensives: When combined with blood pressure medication, there is an increased risk of hypotension and dizziness.
- Anticoagulants: Medications like heparin, warfarin, or newer DOACs increase the risk of bleeding and hematoma at the injection or insertion site.
- Other ED Medications: Combining alprostadil with oral PDE5 inhibitors (like sildenafil or tadalafil) is generally not recommended unless under strict medical supervision, as it significantly increases the risk of priapism.
Managing and Mitigating Side Effects
To maximize the benefits of alprostadil while minimizing risks, patients should follow a structured protocol:
- Proper Titration: The initial dose should always be determined by a healthcare provider. Starting with the lowest effective dose minimizes the risk of pain and priapism.
- Site Rotation: For injections, alternating the side of the penis and the specific entry point helps prevent the buildup of scar tissue (fibrosis).
- Hygiene: Using alcohol swabs and ensuring a sterile environment reduces the risk of infection, which can complicate other side effects.
- Monitoring Neonates: In pediatric settings, continuous pulse oximetry and respiratory monitoring are non-negotiable due to the risk of sudden apnea.
Frequently Asked Questions
What should I do if I experience a "burning" sensation after using MUSE?
Urethral burning is common and usually fades as the medication is absorbed. To mitigate this, ensure you urinate immediately before insertion to provide natural lubrication. If the burning is unbearable, consult your doctor about reducing the dose or switching to an injection-based delivery, which bypasses the urethral lining.
Can alprostadil cause permanent damage to the penis?
Yes, if used incorrectly. The primary risks for permanent damage are untreated priapism (which kills tissue) and long-term fibrosis (which causes curvature). Following the "four-hour rule" for erections and rotating injection sites are the most effective ways to prevent permanent injury.
Is alprostadil safe for people with heart conditions?
Alprostadil is often used by men who cannot take oral ED medications due to nitrate use. However, because sexual activity itself taxes the heart, you must have a cardiovascular clearance from your physician. Systemic absorption is minimal, but the "first-dose" test is essential to ensure you do not experience a significant drop in blood pressure.
Why does my baby need an alprostadil infusion if it causes apnea?
In neonates with "ductal-dependent" heart defects, the closing of the ductus arteriosus is fatal. While apnea is a serious side effect, it is manageable with a ventilator in a NICU setting. The benefit of maintaining blood flow to the body or lungs far outweighs the risk of respiratory depression, which is temporary and treatable.
Does alprostadil affect fertility or sperm quality?
There is no clinical evidence to suggest that alprostadil, when used as directed for ED, has a negative impact on male fertility or sperm health. It acts locally on the smooth muscle and is metabolized quickly.
Practical Recommendation
If you are prescribed alprostadil in 2026, the most critical step you can take is to perform your first dose under direct medical supervision. This allows a clinician to monitor for abnormal blood pressure drops and determine the exact minimum effective dose for your body. If you are using injections, ask your urologist to demonstrate the "manual pressure" technique to minimize bruising. Always keep the contact information for an emergency urology clinic or a hospital with a urologist on-call, should an erection last longer than four hours.
